Clinical Trial Update: A Clinical Study on Therapeutic Double-plasmid Hepatitis B Virus (HBV) DNA Vaccine in Patients With HBeAg-positive Chronic Hepatitis B [Phase 2]

View source ↗

Summary

This entry describes a Phase 2 clinical study evaluating a therapeutic double-plasmid HBV DNA vaccine in patients with HBeAg-positive chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• HBV DNA vaccine (therapeutic double-plasmid) (HBV DNA vaccine, double-plasmid)

Snippet

Sponsor: The 458 Hospital of Chinese PLA | Conditions: Chronic Hepatitis B Patients With HBeAg-positive | Phase 2 | Status: UNKNOWN